Skip to main content
SpringerLink
Log in

Itraconazole contaminated with rilmazafone in Japan

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tsuchiya M, et al. Itraconazole Contaminated with Rilmazafone in Japan: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database Drugs - Real World Outcomes : 31 May 2022. Available from: URL: https://doi.org/10.1007/s40801-022-00306-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Itraconazole contaminated with rilmazafone in Japan. Reactions Weekly 1909, 5 (2022). https://doi.org/10.1007/s40278-022-16292-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16292-8

Search

Navigation